From: The intracerebral hemorrhage acutely decreasing arterial pressure trial II (ICH ADAPT II) protocol
Screening/Randomization | 24 ± 3 h | 48 ± 12 h | Day 7 ± 2 | Day 30 ± 5 | Day 90 ± 30 | |
---|---|---|---|---|---|---|
Eligibility Criteria | □ | |||||
Signed Informed Consent | □ | |||||
Past Medical History | □ | |||||
Vital Signs (BP, HR) Monitoring | □ | □ | □ | □ | □ | □ |
Medications | □ | □ | □ | □ | ||
CT scan | □ | □ | ||||
MRI scan | □ | □ | □ | |||
NIHSS | □ | □ | □ | □ | □ | □ |
Glasgow Coma Scale | □ | □ | □ | □ | □ | □ |
Modified Rankin Scale | □ | □ | □ | □ | ||
Montreal Cognitive Assessment | □ | □ | □ | □ | ||
Barthel Index, EuroQOL | □ | □ | ||||
AE/SAE Reporting | □ | □ | □ | □ | □ | |
End of Study Report | □ |